As of March 2026 Innate Pharma has a market cap of A$0.21 Billion. This makes Innate Pharma the world's 8796th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 9th, 2026 the market cap of Innate Pharma was reported to be: